MRNA vs NATR · rev $145.0M vs P/E 29, rev $239.9M
Moderna Inc (MRNA) versus Natures Sunshine Products Inc (NATR) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Natures Sunshine Products Inc (NATR) is a packaged foods company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported NATR revenue for 2026-06-30 was $239.9M. Net income was $8.7M. Revenue was up 95.2% from 2026-03-31 to 2026-06-30. NATR currently screens at market cap $287.8M and trailing P/E 29.4.
MRNA currently screens at market cap $24.52B. NATR currently screens at market cap $287.8M and trailing P/E 29.4.
Not investment advice. Open the MRNA and NATR stock pages for the full models.
Not investment advice.